Is TG Therapeutics Inc (TGTX) Stock A Better Investment Than Its Rivals?

Goldman lowered the price target for the TG Therapeutics Inc (NASDAQ:TGTX) stock from “a Sell” to “a Neutral”. The rating was released on August 02, 2023, according to finviz. We previously noted in another research note published on June 26, 2023 by Jefferies that resumed the stock to a Buy with a price target of […]

A leader in the success game: TG Therapeutics Inc (TGTX) Stock

Goldman lowered the price target for the TG Therapeutics Inc (NASDAQ:TGTX) stock from “a Sell” to “a Neutral”. The rating was released on August 02, 2023, according to finviz. We previously noted in another research note published on June 26, 2023 by Jefferies that resumed the stock to a Buy with a price target of […]

Offering unique exposure at competitive prices: TG Therapeutics Inc (TGTX) Stock

Goldman lowered the price target for the TG Therapeutics Inc (NASDAQ:TGTX) stock from “a Sell” to “a Neutral”. The rating was released on August 02, 2023, according to finviz. We previously noted in another research note published on June 26, 2023 by Jefferies that resumed the stock to a Buy with a price target of […]

TG Therapeutics Inc (TGTX) Stock: Pessimism is a stepping stone to opportunity

Goldman lowered the price target for the TG Therapeutics Inc (NASDAQ:TGTX) stock from “a Sell” to “a Neutral”. The rating was released on August 02, 2023, according to finviz. We previously noted in another research note published on June 26, 2023 by Jefferies that resumed the stock to a Buy with a price target of […]

A Tale from the Dusty Corner: TG Therapeutics Inc (TGTX) Stock

Goldman lowered the price target for the TG Therapeutics Inc (NASDAQ:TGTX) stock from “a Sell” to “a Neutral”. The rating was released on August 02, 2023, according to finviz. Historical Earnings Surprises and Revenue Forecasts Profit is the most critical financial performance measure. Every investor in a business is looking forward to the earnings report […]

The high-quality value of TG Therapeutics Inc (TGTX) Stock is hidden beneath the surface

Goldman lowered the price target for the TG Therapeutics Inc (NASDAQ:TGTX) stock from “a Sell” to “a Neutral”. The rating was released on August 02, 2023, according to finviz. Historical Earnings Surprises and Revenue Forecasts Profit is the most critical financial performance measure. Every investor in a business is looking forward to the earnings report […]

TG Therapeutics Inc (TGTX) Stock Still Strong Despite Competition

Goldman lowered the price target for the TG Therapeutics Inc (NASDAQ:TGTX) stock from “a Sell” to “a Neutral”. The rating was released on August 02, 2023, according to finviz. Historical Earnings Surprises and Revenue Forecasts Profit is the most critical financial performance measure. Every investor in a business is looking forward to the earnings report […]